4.7 Article

Bidirectional transcription of Linc00441 and RB1 via H3K27 modification-dependent way promotes hepatocellular carcinoma

Journal

CELL DEATH & DISEASE
Volume 8, Issue -, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/cddis.2017.81

Keywords

-

Categories

Funding

  1. National Key Research and Development Program of China [2016YFC0905900]
  2. State Key Program of National Natural Science of China [81430062]
  3. National Basic Research Program of China [2012CB910800]
  4. National Natural Science Foundation [81572370, 81502036]
  5. National Natural Science Foundation of Jiangsu Province [BK20151031]
  6. program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU
  7. Priority Academic Program of Jiangsu Higher Education Institutions

Ask authors/readers for more resources

The retinoblastoma gene (RB1), a known tumor-suppressor gene (TSG), was decreased in multiple cancers including hepatocellular carcinoma (HCC). Here we focused on the bidirectional transcripted long noncoding RNA (Linc00441) with neighbor gene RB1 to investigate whether Linc00441 is involved in the suppression of RB1 in HCC. We found that aberrant upregulated intranuclear Linc00441 was reversely correlated with RB1 expression in human HCC samples. The gain- and loss-of-function investigation revealed that Linc00441 could promote the proliferation of HCC cells in vitro and in vivo with an apoptosis suppression and cell cycle rearrangement. Furthermore, RNA pull-down assay indicated the decreased level of RB1 induced by Linc00441 was associated with the incidental methylation by DNMT3A recruited by Linc00441. On the contrary, the transcription factor (TCF-4) enhanced H3K27 acetylation and direct transcription factor for Linc00441 was responsible for the upregulation of Linc00441 in HCC. In conclusion, the epigenetic interaction between Linc00441 and bidirectional transcripted neighbor RB1 may be a de novo theory cutting-point for the inactivation of RB1 in HCC and may serve as targeting site for tumor therapy in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available